195
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Childhood Chronic Idiopathic Uveitis in a Multicentre International Cohort

, MDORCID Icon, , MD, , MD, , MD, , MD & , MD
Pages 310-319 | Received 31 Jul 2022, Accepted 12 Jan 2023, Published online: 21 Feb 2023
 

ABSTRACT

Importance

Idiopathic uveitis makes up around 50% of non-infectious uveitis but the clinical characteristics in children are poorly understood.

Objective

To report the demographic, clinical characteristics, and outcomes of children with idiopathic non-infectious uveitis (iNIU) in a multicentric retrospective study. 

Results

There were 126 (61 female) children with iNIU. The median age at diagnosis was 9.3 years (3–16 years) . Uveitis was bilateral in 106 patients and anterior in 68.At onset,impaired visual acuity and blindness in the worse eye were reported, in 24.4% and 15.1% patients but at 3 years of follow-up, there was a significant improvement in visual acuity (mean 0.11 SD ±0.50 vs 0.42 SD ± 0.59 p < .001).

Conclusions and relevance

There is a high rate of visual impairment at presentation in children with idiopathic uveitis. The majority of patients have a significant improvement in vision, but 1 in 6 had impaired vision or blindness in their worse eye at 3 years.

KEY POINTS

  • This is a large retrospective study of children with chronic idiopathic uveitis,

  • There is a high rate of visual impairment at presentation in children with idiopathic uveitis. Although visual acuity improves during follow-up, one in six still had impaired vision or blindness in their worse eye at 3 years.

  • At 3 years, more than half of patients were on immunosuppression and one-third were on a biologic agent

Disclosure statement

CG received fees for consultations from Eli Lilly and Company. AVR received fees for consultations from AbbVie, Eli Lilly, UCB and Alimera; Speaker fee: AbbVie, Roche, UCB, Lilly, Novartis, and SOBI.

Data availability statement

Data will be available upon reasonable request.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.